ARTICLE | Clinical News
AngioGenex preclinical data
February 9, 2009 8:00 AM UTC
Data from a xenograft mouse model of cancer showed that AGX-51 produced significant tumor inhibition compared with saline control at day 10 (p<0.01). Additionally, mice treated with AGX-51 plus Taxol...